FDA seeks data on effects of genes, heartburn drugs on Plavix

01/26/2009 | Bloomberg · Los Angeles Times (tiered subscription model)

The FDA asked Bristol-Myers Squibb and Sanofi-Aventis, the manufacturers of Plavix, to study whether genetic factors or proton pump inhibitors -- a class of medicines used to treat acid reflux or heartburn -- interfere with efficacy of the blood thinner. The agency said it may need "several months" to arrive at a conclusion, but it intends to quickly evaluate the research.

View Full Article in:

Bloomberg · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY